E-poster No. / 壁報編號
C23
Title / 題目

Asians May Derive More Survival Benefits from Immunotherapy than Non-Asians

Fitst Author / 第一作者
Shang-Hsuan Peng
Institution / 單位
(1) Department of Oncology, National Taiwan University Hospital Yunlin Branch, Yunlin, Taiwan (2) Department of Oncology, National Taiwan University Hospital, Taipei, Taiwan.
Author Group / 作者群
Ching-Hung Lin (1, 2, 3), I-Chun Chen (1, 2, 4), Shu-Min Huang (1), Fu-Chang Hu (5, 6), Yen-Shen Lu (1, 2, 3, 4)
Author Group Institution/ 作者群單位
(1) Department of Oncology, National Taiwan University Hospital, Taipei, Taiwan. (2) Department of Medical Oncology, National Taiwan University Cancer Center, Taipei, Taiwan. (3) Department of Internal Medicine, College of Medicine, National Taiwan University, Taipei, Taiwan. (4) Graduate Institute of Oncology, College of Medicine, National Taiwan University, Taipei, Taiwan. (5) Graduate Institute of Clinical Medicine and School of Nursing, College of Medicine, National Taiwan University, Taipei, Taiwan. (6) Statistical Consulting Clinic, International-Harvard Statistical Consulting Company, Taipei, Taiwan.
Category / 主題分類
Clinical Research
Keyword / 關鍵字
Pembrolizumab; Metastatic cancer; Asians; Overall Survival